GSK plc reported that on February 18, 2026, it purchased 410,000 ordinary shares at an average price of 2,268.77p as part of its ongoing buyback program. Since February 17, 2026, a total of 830,000 shares have been bought back, leaving 240,721,094 shares in treasury.